Sanjeev Jain
#562Managing Director
54
Age
40y
Exp
21y
Tenure
6/10
Risk
🎓 Graduate in Medical Sciences
📜 MBA
🏛️ None
CompensationTBP
Personality
6
Open
7
Cons
5
Extr
5
Agre
4
Neur
Akums Drugs
Healthcare · Mid Cap
High Growth · Performance-Driven
About
Sanjeev Jain is the Managing Director of Akums Drugs, a Mid Cap company in the Healthcare sector with a market cap of ₹8K Cr. A Visionary leader with 40 years of experience, he is known for intuition-driven decision-making and organic builder strategy. His leadership has been characterized by building a massive, innovation-led CDMO business model with significant infrastructure investment.
FAQ
What is Sanjeev Jain's leadership style?
Sanjeev Jain is classified as a Visionary leader. He is intuition-driven in decision-making, with a category creator motivation and startup-speed pace of execution.
What is Sanjeev Jain's educational background?
Sanjeev Jain holds a Graduate in Medical Sciences and a MBA.
Who is the CEO of Akums Drugs?
Sanjeev Jain is the Managing Director of Akums Drugs. He has been with the company for 21 years and in the current role for 21 years.
Leadership DNA
ArchetypeVisionary
MotivationCategory Creator
CrisisSteady Hand
DecisionIntuition-Driven
GrowthOrganic Builder
PeopleRelationship Led
InnovationFast-Follower
PaceStartup-Speed
PurposeProfit-Pure
CustomerB2B-Enterprise
EmployerDemanding Machine
BrandTechnical-Expert
FocusProduct Innovation
OrientationDeep Specialist
Leadership Evidence
“His leadership has been characterized by building a massive, innovation-led CDMO business model with significant infrastructure investment.”
⚡ Crisis●●●○○
Akums has maintained a consistent focus on its core CDMO business model throughout market volatility rather than pivoting or aggressively restructuring.
🎯 Motivation●●●●○
Sanjeev Jain built Akums into India's largest contract research and manufacturing services (CRAMS) player by defining the outsourced pharmaceutical manufacturing category.
👥 People●●●○○
As a promoter-led business, the company relies on long-term personal oversight and a tight-knit management structure characteristic of successful Indian family-founded enterprises.
📈 Growth●●●●○
The company's growth has been primarily driven by the continuous expansion of its own manufacturing facilities and internal R&D capabilities.
💡 Innovation●●●●○
As a leading CDMO, Akums excels at rapid formulation development and scaling production for diverse pharmaceutical clients rather than inventing novel molecular entities.
🏃 Pace●●●●○
The company maintains a high-velocity operational model, managing a massive portfolio of thousands of product formulations and rapid commercialization cycles for clients.
🌱 Purpose●●●○○
The company operates primarily as a high-volume contract manufacturer focused on commercial efficiency and cost-effective production for its B2B partners.
🏷️ Brand●●●●○
Their reputation is built on deep technical proficiency in complex drug delivery systems and their ability to handle diverse therapeutic segments for major pharma brands.
🤝 Customer●●●●●
Akums is a pure-play contract development and manufacturing organization (CDMO) that serves pharmaceutical companies rather than end-consumers.
💼 Employer●●●○○
The nature of high-volume, high-compliance pharmaceutical manufacturing requires rigorous adherence to schedules and performance metrics characteristic of a high-pressure production environment.
📋 Mandate
Needs to drive R&D-led growth and portfolio expansion to capitalize on its position as a major contract manufacturer.
🏢 Culture●●●○○
High growth, volume-driven generic manufacturing environment requiring intense operational rigor.
Financials
Revenue FY25₹4K Cr
PAT FY25₹338 Cr
Rev CAGR 5Y3.7%
OPM7.6%
NPM8.3%
ROE11.1%
ROCE9.6%
P/E22.5
Fwd P/E19
P/B2.3
D/E2.9
Promoter84.9%
Institutional13.6%
Mkt Cap₹8K Cr
Compensation
To Be Published
Data being verified from audited reports
